The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • The variant label for this record ("m.5549G>A") does not appear to be in HGVS format
  • Despite there being a valid 'cspec' property in the messages there's a discrepancy in message contents and CSPEC data: * Message Gene: MT-TW CSPEC Genes: [] * Message MONDOs: MONDO:0044970 CSPEC MONDO: []
  • No CSPEC computed assertion could be determined for this classification!


Variant: m.5549G>A

CA120540

9554 (ClinVar)

Gene: MT-TW
Condition: mitochondrial disease
Inheritance Mode: Mitochondrial inheritance
UUID: 94bc666c-2358-4ec0-95eb-3fd6ce3889d3
Approved on: 2024-04-23
Published on: 2025-07-09

HGVS expressions

NC_012920.1:m.5549G>A
J01415.2:m.5549G>A

Uncertain Significance

Met criteria codes 3
PM2_Supporting PM6_Supporting PP3
Not Met criteria codes 1
PS3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Mitochondrial Disease Nuclear and Mitochondrial Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1_mtDNA

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Mitochondrial Diseases VCEP
The m.5549G>A variant in MT-TW has been reported in two individuals with primary mitochondrial disease to date (PMIDs: 7695240, 34276539; PS4_supporting). The first reported case was a man with onset at age 40 years of personality and behavioral changes followed by progressive cognitive decline, hearing loss, ataxia, chorea, dysarthria, and axonal neuropathy, and he died at age 53 years (PMID: 7695240). Brain imaging showed atrophy of the cerebrum, cerebellum, and brainstem. Muscle biopsy showed COX-negative and ragged red fibers. The variant was present at 40% heteroplasmy in blood, 83-86% in skeletal muscle, and 51-93% in organs on autopsy (liver, optic nerve, lung, heart, kidney, cerebral cortex, cerebellum). There was no mention of testing in family members. The second reported case was a 26-year-old man with onset in adolescence of epilepsy, ataxia, dystonia, impaired cognition, and hearing loss (PMID: 34276539). Brain imaging showed leukoencephalopathy and cerebral atrophy in addition to calcifications of the bilateral basal ganglia, thalamus, and cerebellar dentate nuclei. Muscle biopsy showed ragged blue and COX-deficient fibers. The variant was present at 5.4% heteroplasmy in blood and 61.5% in muscle. The variant was absent in his mother’s blood (PMID: 34276539; PM6_supporting). This variant is absent in the MITOMAP GenBank dataset, gnomAD v3.1.2, and the Helix dataset (PM2_supporting). The computational predictor MitoTIP suggests this variant is pathogenic (88.3 percentile) and HmtVAR predicts it to be pathogenic with a score of 0.35 (PP3). There are no cybrids, single fiber studies, or other functional assays reported on this variant. In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on April 23, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PS4_supporting, PM6_supporting, PM2_supporting, PP3.
Met criteria codes
PM2_Supporting
This variant is absent in the MITOMAP GenBank dataset, gnomAD v3.1.2, and the Helix dataset (PM2_supporting).
PM6_Supporting
The second reported case was a 26-year-old man with onset in adolescence of epilepsy, ataxia, dystonia, impaired cognition, and hearing loss (PMID: 34276539). Brain imaging showed leukoencephalopathy and cerebral atrophy in addition to calcifications of the bilateral basal ganglia, thalamus, and cerebellar dentate nuclei. Muscle biopsy showed ragged blue and COX-deficient fibers. The variant was present at 5.4% heteroplasmy in blood and 61.5% in muscle. The variant was absent in his mother’s blood (PMID: 34276539; PM6_supporting).
PP3
The computational predictor MitoTIP suggests this variant is pathogenic (88.3 percentile) and HmtVAR predicts it to be pathogenic with a score of 0.35 (PP3).
Not Met criteria codes
PS3
There are no cybrids, single fiber studies, or other functional assays reported on this variant.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.